Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-043581

Chief Business Officer sold 40,000 shares at an average $14.36 ($574,200)

  • Chief Business Officer acquired 40,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Virani Shafique · Chief Business Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-25 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $2.22 $44,400 163,954 D
2023-07-25 Sale : show line 2 in the form 10b5-1 −20,000 $14.30 $286,000 143,954 D
2023-07-26 Exercise or conversion : show line 3 in the form 10b5-1 +20,000 $2.22 $44,400 163,954 D
2023-07-26 Sale : show line 4 in the form 10b5-1 −20,000 $14.41 $288,200 143,954 D
Open-market sales · 40,000 sh · avg $14.36 · $574,200

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-07-25 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −20,000 $2.22 2030-03-03 20,000 489,469 D
2023-07-26 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −20,000 $2.22 2030-03-03 20,000 469,469 D
Loading xslF345X05/doc4.xml…